Interactions of allergic rhinitis and bronchial asthma at mucosal immunology level

Kremena Naydenova; Tsvetelina Velikova; Vasil Dimitrov; Kremena Naydenova; Tsvetelina Velikova; Vasil Dimitrov

doi:10.3934/Allergy.2019.1.1

AIMS Allergy and Immunology

2019, Volume 3, Issue 1: 1-12. doi: 10.3934/Allergy.2019.1.1

Previous Article Next Article

Review

Interactions of allergic rhinitis and bronchial asthma at mucosal immunology level

1.
Clinical Center of Allergology, University Hospital ‘Alexandrovska’; Department of internal medicine, Medical University of Sofia, Georgi Sofyiski 1 str., Sofia
2.
Clinical Immunology, University Hospital Lozenetz, 1 Kozyak str, 1407 Sofia

Received: 03 November 2018 Accepted: 23 January 2019 Published: 25 January 2019

Allergic rhinitis (AR) and bronchial asthma (BA) could be described as different aspects of one systemic disorder, where a mutual relationship is suggested founded on the well-known link between distinct mucosal sites in the organism. Moreover, several studies discuss the intimate association between AR and BA, including the observation that AR occurs usually as the first manifestation of the allergic respiratory (atopic) march. This review focuses on the various aspects of nose and lungs interaction during the course of the allergic disease. The dysfunction of the upper and lower airways is observed often simultaneously. It is thought that AR and BA share common pathogenic features and embryological, histological, anatomical and physiological characteristics. Furthermore, the data on the common nasal-bronchial reflex, inflammatory mechanisms, similar triggers, and genetic factors, clinical and epidemiological observations, the effect from the administered therapy, all confirm the suggested relation between AR and BA. The nasal-bronchial cross-talk rely on three different pathways: the immunological in the respiratory mucosa, the neural, and the circulatory pathway. In conclusion, AR and BA often occur simultaneously and share similar pathophysiological mechanisms. Nevertheless, the observation that the similar treatment is effective in both patients, gives hope for the management and prognosis of these patients.
- allergic rhinitis,
- bronchial asthma,
- mucosal inflammation,
- allergy,
- Th2 cells,
- cytokines
Citation: Kremena Naydenova, Tsvetelina Velikova, Vasil Dimitrov. Interactions of allergic rhinitis and bronchial asthma at mucosal immunology level[J]. AIMS Allergy and Immunology, 2019, 3(1): 1-12. doi: 10.3934/Allergy.2019.1.1

Related Papers:

Abstract

Allergic rhinitis (AR) and bronchial asthma (BA) could be described as different aspects of one systemic disorder, where a mutual relationship is suggested founded on the well-known link between distinct mucosal sites in the organism. Moreover, several studies discuss the intimate association between AR and BA, including the observation that AR occurs usually as the first manifestation of the allergic respiratory (atopic) march. This review focuses on the various aspects of nose and lungs interaction during the course of the allergic disease. The dysfunction of the upper and lower airways is observed often simultaneously. It is thought that AR and BA share common pathogenic features and embryological, histological, anatomical and physiological characteristics. Furthermore, the data on the common nasal-bronchial reflex, inflammatory mechanisms, similar triggers, and genetic factors, clinical and epidemiological observations, the effect from the administered therapy, all confirm the suggested relation between AR and BA. The nasal-bronchial cross-talk rely on three different pathways: the immunological in the respiratory mucosa, the neural, and the circulatory pathway. In conclusion, AR and BA often occur simultaneously and share similar pathophysiological mechanisms. Nevertheless, the observation that the similar treatment is effective in both patients, gives hope for the management and prognosis of these patients.

Conflict of interest

All authors declare no conflicts of interest in this paper.

References

[1]	Blackley CH (1873) Expreminets with pollen. In: Experimental researches of the causes and nature of catarrhus aestivus (hay-fever and hay-asthma), 1^st ed, London: Oxford Historical Books, 73–103.
[2]	Braunstahl GJ (2005) The unified immune system: Respiratory tract–nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 115: 142–148. doi: 10.1016/j.jaci.2004.10.041
[3]	Togias A (1999) Mean chanisms of nose-lung tnteraction. Allergy 54: 94–105. doi: 10.1111/j.1398-9995.1999.tb04410.x
[4]	Compalati E, Ridolo E, Passalacqua G, et al. (2010) The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol 6: 413–423. doi: 10.1586/eci.10.15
[5]	Bousquet J, Vignola A, Leynaert B, et al. (2003) Links between rhinitis and asthma. Allergy 58: 733–741. doi: 10.1034/j.1398-9995.2003.00076.x
[6]	Mehta P (2014) Allergic rhinitis and bronchial asthma. J Assoc Physicians India 62: 23–26.
[7]	Guerra S, Sherrill DL, Martinez FD, et al. (2002) Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 109: 419–425. doi: 10.1067/mai.2002.121701
[8]	Bergeron MD, Hamid Q (2005) Relationship between asthma and rhinitis: Epidemiologic, pathophysiologic and therapeutic aspects. Allergy Asthma Clin Immunol 1: 81–87.
[9]	Feng Ch, Miller MD, Simon RA (2012) The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy 26: 187–190. doi: 10.2500/ajra.2012.26.3762
[10]	Simons FE (1999) Allergic rhinobronchitis: The asthma-allergic rhinitis link. J Allergy Clin Immunol 104: 534–540. doi: 10.1016/S0091-6749(99)70320-9
[11]	Bousquet J, van Cauwemberge P, Khaltaev N, et al. (2001) Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108: S147–S334. doi: 10.1067/mai.2001.118891
[12]	Valero A, Pereira C, Loureiro C, et al. (2009) Interrelationship between skin sensitization, rhinitis and asthma in patients with allergic rhinitis: study of Spain and Portugal. J Investig Allergol Clin Immunol 19: 167–172.
[13]	World Health Organization (WHO) (1995) Global strategy for asthma management and prevention.
[14]	Leynaert B, Neukirch F, Demoly P, et al. (2000) Epidemiological evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 106: 201–205. doi: 10.1067/mai.2000.108604
[15]	Thomas M (2006) Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med 6: S4. doi: 10.1186/1471-2466-6-S1-S4
[16]	Blaiss MS (2005) Rhinitis-asthma connection: epidemiological and pathophysiological basis. Allergy Asthma Proc 26: 35–40.
[17]	Caimmi D, Marseglia A, Pieri G, et al. (2012) Nose and lungs: one way, one disease. Ital J Pediatr 38: 60. doi: 10.1186/1824-7288-38-60
[18]	Huovinen E, Kaprio J, Laitinen LA, et al. (1999) Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 115: 928–936. doi: 10.1378/chest.115.4.928
[19]	Borish L (2003) Allergic rhinitis. J Allergy Clin Immunol 112: 1021–1031. doi: 10.1016/j.jaci.2003.09.015
[20]	Corren J (1997) Allergic rhinitis and asthma: How important is the link? J Allergy Clin Immunol 99: S781–S786. doi: 10.1016/S0091-6749(97)70127-1
[21]	Durham SR (1999) Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy 54: 124–131. doi: 10.1111/j.1398-9995.1999.tb04414.x
[22]	Braunstahl GJ, Kleinjan A, Overbeek SE, et al. (2000) Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 161: 2051–2057. doi: 10.1164/ajrccm.161.6.9906121
[23]	Braunstahl GJ, Overbeek SE, Kleinjan A, et al. (2001) Nasal allergen challenge induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107: 469–476. doi: 10.1067/mai.2001.113046
[24]	Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. (2001) Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in the nasal and bronchial mucosa. Am J Respir Crit Care Med 164: 858–865. doi: 10.1164/ajrccm.164.5.2006082
[25]	Naydenova K, Rusekov N, Dimitrov V (2018) Correlations between allergic rhinitis and bronchial asthma as proof of the single breathing times. Allergy Hypersensitivity Asthma 14: 53–58.
[26]	Burrows B, Lebowitz MD, Barbee RA, et al. (1991) Findings before the diagnosis of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 88: 870–877. doi: 10.1016/0091-6749(91)90243-H
[27]	Serrano C, Valero A, Picado C (2005) Rhitinis and asthma: one airway, one disease Arch Bronconeumol 41: 569–578.
[28]	Bousquet J, Jacot W, Vignola A, et al. (2004) Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 113: 43–49. doi: 10.1016/j.jaci.2003.09.047
[29]	Passalacqua G, Ciprandi G, Canonica G (2000) United airways disease: therapeutic aspects. Thorax 55: S26–S27. doi: 10.1136/thorax.55.suppl_2.S26
[30]	James A, Carrol N (2000) Airway smooth muscle in health and disease: methods of measurement and relation to function. Eur Resp J 15: 782–789. doi: 10.1034/j.1399-3003.2000.15d25.x
[31]	Ciprandi G, Cirillo I (2007) The lower airway pathology of rhinitis. J Allergy Clin Immunol 119: 1557–1558. doi: 10.1016/j.jaci.2007.01.048
[32]	Cingi C, Muluk NB, Cobanoqlu B, et al. (2015) Nasobronchial Interaction. World J Clin Cases 3: 499–503. doi: 10.12998/wjcc.v3.i6.499
[33]	Perez-Rogers JF, Gerrein J, Anderlind C, et al. (2017) Shared gene expression alterations in nasal and bronchial epithelium for lung cancer detection. J Nati Cancer Inst 109: djw327.
[34]	Pawankar R (2007) Inflammatory mechanisms in allergic rhinitis. Curr Opin Allergy Clin Immunol 7: 1–4. doi: 10.1097/ACI.0b013e3280145347
[35]	Roitt I, Brostoff J, Male D (1993) Cell migration and inflammation, In: Immunology. London: Mosby, 13–13.8.
[36]	Roitt I, Brostoff J, Male D (1993) Antigen Presentation, In: Immunology. London: Mosby, 13–13.8.
[37]	Ciprandi G, Pronzato C, Ricca V, et al. (1994) Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J Allergy Clin Immunol 94: 738–774. doi: 10.1016/0091-6749(94)90182-1
[38]	Liu CM, Shun CT, ChengYK (1998) Soluble adhesion molecules and cytokines in perennial allergic rhinitis. Ann Allergy Asthma Immunol 81: 176–180. doi: 10.1016/S1081-1206(10)62806-2
[39]	Varner AE, Lemanske RF (2000) The early and late asthmatic response to allergen. In: Asthma and Rhinitis. 2 Eds., Oxford: Blackwell Science, 1172–1185.
[40]	McDougall CM, Blaylock MG, Douglas JG, et al. (2008) Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 39: 560–568. doi: 10.1165/rcmb.2007-0325OC
[41]	Togias A (2000) Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 105: S599–S604. doi: 10.1067/mai.2000.106885
[42]	Canonica G, Compalati E (2009) Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol 158: 260–271. doi: 10.1111/j.1365-2249.2009.04017.x
[43]	Ciprandi G, Cirillo I, Pistorio A (2008) Impact of allergic rhinitis on asthma: effects on spirometric parameters. Allergy 63: 255–260.
[44]	Miller MR, Hankinson J, Brusque V, et al. (2005) Standardization of spirometry. Eur Respir J 26: 319–338. doi: 10.1183/09031936.05.00034805
[45]	Marseglia GL, Tosca M, Cirillo I, et al. (2007) Role of forced expiratory flow at 25–75% as a early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 28: 74–78. doi: 10.2500/aap.2007.28.2920
[46]	Ciprandi G, Cirillo I, Signori A (2011) Impact of allergic rhinitis on bronchi: An 8-year follow-up study. Am J Rhinol Allergy 25: e72–e76. doi: 10.2500/ajra.2011.25.3607
[47]	Ciprandi G, Vizzaccaro A, Pallestrini E, et al. (2006) Role of FEF 25-75 as a early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol 20: 641–647. doi: 10.2500/ajr.2006.20.2914
[48]	Corren J, Adinoff AD, Buchmeier AD, et al. (1992) Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 90: 250–256. doi: 10.1016/0091-6749(92)90079-H
[49]	Wilson AM, Orr LC, Sims EJ, et al. (2001) Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 31: 61–68. doi: 10.1111/j.1365-2222.2001.00964.x
[50]	Crystal-Peters J, Neslusan C, Crown WH, et al. (2002) Treatment of lergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 109: 57–62. doi: 10.1067/mai.2002.120554
[51]	Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. (2002) Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 109: 636–642. doi: 10.1067/mai.2002.123237
[52]	Greiff L, Andersson M, Svensson C, et al. (1998) Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 11: 1268–1273. doi: 10.1183/09031936.98.11061268
[53]	Dziadzio LL, Busse W (2002) Anti-IgE and the Treatment of Asthma and Allergic Disease, In: Agosti BJ. Biotherapeutic Approaches to Asthma, 3Eds.
[54]	Samitas K, Delimpoura V, Zervas E, et al. (2015) Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives. Eur Respir Rev 24: 594–601. doi: 10.1183/16000617.00001715
[55]	Prickett SR, Rolland JM, O'Hehir RE (2015) Immunoregulatory T cell epitope peptides: the new frontier in allergytherapy. Clin Exp Allergy 45: 1015–1026. doi: 10.1111/cea.12554

Reader Comments

Your name:*

Email:*
© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)